Sildenafil citrate therapy in 22 dogs with pulmonary hypertension.

Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. Abstract Text:

Heidi B Kellum,Rebecca L Stepien,Heidi B Kellum,Rebecca L Stepien,Heidi B Kellum,Rebecca L Stepien,

BACKGROUND: Pulmonary hypertension (PH) is a disease condition characterized by abnormally increased pulmonary artery pressures and often is associated with a poor prognosis. Sildenafil is a phosphodiesterase inhibitor that causes pulmonary arterial vasodilation and reduction in pulmonary artery pressures. HYPOTHESIS: Treatment with sildenafil will improve echocardiographic determinants of PH in dogs, while also improving quality of life and survival. ANIMALS: Twenty-two dogs with clinical and echocardiographic evidence of pulmonary hypertension. METHODS: A retrospective study evaluating the effects of sildenafil on physical examination, ECG and radiographic findings, blood pressure and echocardiographic findings of PH, clinical score, and outcome was completed. PH was defined as a peak tricuspid regurgitation flow velocity > or = 2.8 m/s or a peak pulmonic insufficiency flow velocity > or = 2.2 m/s. RESULTS: Sixteen of 22 dogs with PH were elderly females of small body size. Their clinical score was significantly improved (P = .0003) with sildenafil treatment, but physical examination findings remained unchanged. Heart rate, respiratory rate, vertebral heart size, ECG heart rate, and systolic blood pressure did not change significantly with sildenafil treatment (P > .05). Peak tricuspid regurgitation flow velocities did not change significantly with the treatment of sildenafil, but selected systolic time intervals were significantly improved. Survival times for all dogs ranged from 8 to > 734 days. CONCLUSIONS AND CLINICAL IMPORTANCE: Sildenafil did not significantly lower the degree of measurable PH in dogs. Clinical improvement and increased quality of life was seen with sildenafil treatment, despite lack of significant change in other variables.

Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. Publishing Authors By Initials

HB Kellum,RL Stepien,HB Kellum,RL Stepien,HB Kellum,RL Stepien,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of veterinary internal medicine / American

VOLUME: 21

Page Numbers: 1258-64

Journal Abbreviation: J. Vet. Intern. Med.

ISSN: 0891-6640

DAY: 16

MONTH: 01

YEAR: 2008

Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8708660

Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Sildenafil citrate therapy in 22 dogs with pulmonary hypertension.

AFFILIATION: Section of Cardiology, Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA. kellumh@svm.vetmed.wisc.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Vet Intern Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Sildenafil citrate therapy in 22 dogs with pulmonary hypertension Related Publications

• Ancient divisions, recent expansions: phylogeography and population genetics of the round goby Apollonia melanostoma.
• Dynamic heart phantom for the quality control of SPECT equipment.
• Interaction of human SUV3 RNA/DNA helicase with BLM helicase; loss of the SUV3 gene results in mouse embryonic lethality.
• Molecular, morphological, and biogeographic resolution of cryptic taxa in the Greenside Darter Etheostoma blennioides complex.
• On the syndrome of Arnold-Chiari; report of a case.
• Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism.
• Sildenafil citrate therapy in 22 dogs with pulmonary hypertension.
• The place of somatostatin analogs in the diagnosis and treatment of the neuoroendocrine glands tumors.
• [Investigations on the influence of portal vein hypertension on the topomorphological structure of the thoracic duct wall (author's transl)]
• [Not Available.]
• [PHYSIOPATHOLOGICAL AND CLINICAL ASPECTS OF ALDOSTERONISM.]